Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Wysokiński

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Psychiatria Danubina|June 19, 2012
Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - case reportAdam Wysokiński
Psychiatria Danubina|April 15, 2023
Tolerability and Safety of 219 Transcranial Direct Current Stimulation (TDCS) 2.0 mA Sessions in Adult Patients with SchizophreniaAdam Wysokiński
Nordic Journal of Psychiatry|November 10, 2015
Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophreniaAdam Wysokiński
Diabetes & Metabolic Syndrome|October 15, 2014
Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapyAdam Wysokiński
Psychiatria Danubina|March 15, 2017
Serum folate and homocysteine in chronic schizophrenic patientsAdam Wysokiński
Clinical Neuropharmacology|January 13, 2015
Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapyAdam Wysokiński
The Journal of ECT|April 24, 2022
EEG_ADC: Digitizer and Analyzer of Electroconvulsive Therapy Paper Electroencephalogram RecordingsAdam Wysokiński
Psychiatry and Clinical Neurosciences|July 22, 2014
Changes of metabolic parameters during electroconvulsive treatment of schizophrenia: Preliminary resultsAdam Wysokiński
Schizophrenia Research|April 7, 2020
Successful replacement of electroconvulsive treatment (ECT) with transcranial direct current stimulation (tDCS) in severe, treatment-refractory catatonic schizophrenia: Case studyAdam Wysokiński
Schizophrenia Research|July 19, 2016
Obestatin may be involved in clozapine-induced changes in glucose metabolismAdam Wysokiński
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Psychiatria Danubina|June 19, 2012
Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - case reportAdam Wysokiński
Psychiatria Danubina|April 15, 2023
Tolerability and Safety of 219 Transcranial Direct Current Stimulation (TDCS) 2.0 mA Sessions in Adult Patients with SchizophreniaAdam Wysokiński
Nordic Journal of Psychiatry|November 10, 2015
Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophreniaAdam Wysokiński
Diabetes & Metabolic Syndrome|October 15, 2014
Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapyAdam Wysokiński
Psychiatria Danubina|March 15, 2017
Serum folate and homocysteine in chronic schizophrenic patientsAdam Wysokiński
Clinical Neuropharmacology|January 13, 2015
Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapyAdam Wysokiński
The Journal of ECT|April 24, 2022
EEG_ADC: Digitizer and Analyzer of Electroconvulsive Therapy Paper Electroencephalogram RecordingsAdam Wysokiński
Psychiatry and Clinical Neurosciences|July 22, 2014
Changes of metabolic parameters during electroconvulsive treatment of schizophrenia: Preliminary resultsAdam Wysokiński
Schizophrenia Research|April 7, 2020
Successful replacement of electroconvulsive treatment (ECT) with transcranial direct current stimulation (tDCS) in severe, treatment-refractory catatonic schizophrenia: Case studyAdam Wysokiński
Schizophrenia Research|July 19, 2016
Obestatin may be involved in clozapine-induced changes in glucose metabolismAdam Wysokiński
Pageof 8